Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
BMC Complementary Medicine and Therapies
Published in: BMC Complementary Medicine and Therapies 1/2018

Open Access 01-12-2018 | Research article

Associations between the use of herbal medicines and adverse pregnancy outcomes in rural Malawi: a secondary analysis of randomised controlled trial data

Authors: Collins Zamawe, Carina King, Hannah Maria Jennings, Edward Fottrell

Published in: BMC Complementary Medicine and Therapies | Issue 1/2018

Login to get access

Abstract

Background

The use of herbal medicines during pregnancy is very high globally and previous studies have pointed out possible associations with adverse pregnancy outcomes. Nevertheless, the safety of herbal medicines in pregnancy is under-explored in low-income countries experiencing high maternal and neonatal complications. We investigated the associations between self-reported use of Mwanamphepo (a group of herbal medicines commonly used to induce or hasten labour) and adverse maternal and neonatal outcomes in rural Malawi.

Methods

We conducted a cross-sectional analysis of secondary household data relating to 8219 births that occurred between 2005 and 2010 in Mchinji district, Malawi. The data were collected as part of a cluster-randomised controlled trial (RCT) that evaluated community interventions designed to reduce maternal and neonatal mortality. Data were gathered on maternity history, demographic characteristics, pregnancy outcomes and exposure to Mwanamphepo. Associations between self-reported use of Mwanamphepo and maternal morbidity as well as neonatal death or morbidity were examined using mixed-effects models, adjusted for relevant covariates. All analyses were also adjusted for the clustered nature of the survey.

Results

Of the 8219 births, Mwanamphepo was used in 2113 pregnancies, representing an estimated prevalence of 25.7%. The self-reported use of Mwanamphepo was significantly associated with increased occurrence of maternal morbidity and neonatal death or morbidity. Specifically, the odds of maternal morbidity were 28% higher among self-reported users than non-users of Mwanamphepo (AOR = 1.28; 95% CI = 1.09–1.50) and the probabilities of neonatal death or morbidity were 22% higher (AOR =1.22; 95% CI = 1.06–1.40) among neonates whose mother reportedly used Mwanamphepo than those who did not.

Conclusion

The use of Mwanamphepo was associated with adverse pregnancy outcomes in rural Malawi. Thus, herbal medicines may not be safe in pregnancy. Where possible, pregnant women should be discouraged from using herbal medicines of unconfirmed safety and those who report to have used should be closely monitored by health professionals. The study was limited by the self-report of exposure and unavailability of data relating to some possible confounders.
Literature
1.
2.
World Health Organisation. WHO guidelines for good manufacturing practices (GMP) of herbal medicines. Geneva: World Health Organisation; 2007.
3.
Trabace L, Tucci P, Ciuffreda L, et al. “Natural” relief of pregnancy-related symptoms and neonatal outcomes: above all do no harm. J Ethnopharmacol. 2015;174:396–402.CrossRefPubMed
4.
Holst L, Wright D, Haavik S, Nordeng H. The use and the user of herbal remedies during pregnancy. J. Altern. Complement. Med. 2009;15(7):787–92.CrossRefPubMed
5.
Al-Ramahi R, Jaradat N, Adawi D. Use of herbal medicines during pregnancy in a group of Palestinian women. J Ethnopharmacol. 2013;150(1):79–84.CrossRefPubMed
6.
Chuang C, Chang P, Hsieh W, Tsai Y, Lin S, Chen P. Chinese herbal medicine use in Taiwan during pregnancy and the postpartum period: a population-based cohort study. Int J Nurs Stud. 2009;46(6):787–95.CrossRefPubMed
7.
Mureyi DD, Monera TG, Maponga CC. Prevalence and patterns of prenatal use of traditional medicine among women at selected Harare clinics: a cross-sectional study. BMC Complement. Altern. Med. 2012;12(1):164–70.CrossRefPubMedPubMedCentral
8.
Simpson M, Parsons M, Greenwood J, Wade K. Raspberry leaf in pregnancy: its safety and efficacy in labor. J. Midwifery Womens Health. 2001;46(2):51–9.CrossRefPubMed
9.
Mothupi MC. Use of herbal medicine during pregnancy among women with access to public healthcare in Nairobi, Kenya: a cross-sectional survey. BMC Complement Altern Med. 2014;14:432.CrossRefPubMedPubMedCentral
10.
Law Kim S, Soon LK. Herbal medicines: Malaysian Women's knowledge and practice. Evid. Based Complement. Alternat. Med. 2013;2013:1–10.
11.
Jackson EA. Is ginger root effective for decreasing the severity of nausea and vomiting in early pregnancy? J. Fam. Pract. 2001;50(8):720.PubMed
12.
Maimbolwa MC, Yamba B, Diwan V, Ransjö-Arvidson A. Cultural childbirth practices and beliefs in Zambia. J Adv Nurs. 2003;43(3):263–74.CrossRefPubMed
13.
Seljeskog L, Sundby J, Chimango J. Factors influencing Women's choice of place of delivery in rural Malawi-an explorative study. Afr J Reprod Health. 2006;10(3):66–75.CrossRefPubMed
14.
Holst L, Wright D, Nordeng H, Haavik S. Use of herbal preparations during pregnancy: focus group discussion among expectant mothers attending a hospital antenatal clinic in Norwich UK. Complement Ther Clin Pract. 2009;15(4):225–9.CrossRefPubMed
15.
World Health Organisation. WHO Traditional Medicine Strategy. WHO: Geneva; 2014.
16.
Teoh CS, Aizul MHI, WFS WM, et al. Herbal ingestion during pregnancy and post-partum period is a cause for concern. Med J Malaysia. 2013;68(2):157–60.PubMed
17.
18.
19.
Gallo M, Sarkar M, Au W, et al. Pregnancy outcome following gestational exposure to echinacea: a prospective controlled study. Arch Intern Med. 2000;160(20):3141–3.CrossRefPubMed
20.
Nordeng H, Bayne K, Havnen G, Paulsen B. Use of herbal drugs during pregnancy among 600 Norwegian women in relation to concurrent use of conventional drugs and pregnancy outcomes. Complement Ther Clin Pract. 2011;17(3):147–51.CrossRefPubMed
21.
Ab Rahman A, Ahmad Z, Naing L, Sulaiman SA, Hamid AM, Daud WN. The use of herbal medicines during pregnancy and perinatal mortality in Tumpat District, Kelantan, Malaysia. Southeast Asian J. Trop. Med. Public Health. 2007;38(6):1150–7.PubMed
22.
Boel ME, Lee SJ, Rijken MJ, et al. Castor oil for induction of labour: not harmful, not helpful. Aust. N. Z. J. Obstet. Gynaecol. 2009;49(5):499–503.CrossRefPubMed
23.
Qiu H, Zhu H, Ouyang W, Wang Z, Sun H. Clinical effects and mechanism of chanlibao in accelerating second stage of labor. J. Tongji Med. Univ. = Tong Ji Yi Ke Da Xue Xue Bao. 1999;19(2):141–4.PubMed
24.
Mabina MH, Pitsoe SB, Moodley J. The effect of traditional herbal medicines on pregnancy outcome. The king Edward VIII hospital experience. S. Afr. Med. J. = Suid-Afrikaanse Tydskrif Vir Geneeskunde. 1997;87(8):1008–10.PubMed
25.
Chuang C-H, Doyle P, Wang J-D, Chang P-J, Lai J-N, Chen P-C. Herbal medicines used during the first trimester and major congenital malformations: an analysis of data from a pregnancy cohort study. Drug Saf. 2006;29(6):537–48.CrossRefPubMed
26.
Veale DJ, Furman KI, Oliver DW. South African traditional herbal medicines used during pregnancy and childbirth. J Ethnopharmacol. 1992;36(3):185–91.CrossRefPubMed
27.
Nergard CS, Ho TPT, Diallo D, Ballo N, Paulsen BS, Nordeng H. Attitudes and use of medicinal plants during pregnancy among women at health care centers in three regions of Mali West-Africa. J Ethnobiol Ethnomed. 2015;11:73.CrossRefPubMedPubMedCentral
28.
Ronsmans C, Graham WJ. Lancet maternal survival series steering g. Maternal mortality: who, when, where, and why. Lancet. 2006;368(9542):1189–200.CrossRefPubMed
29.
WHO, UNICEF, UNFPA, World Bank Group, United Nations Population Division. Trends in maternal mortality: 1990 to 2015: estimates by WHO, UNICEF, UNFPA, World Bank Group and the United Nations population division. Geveva: World Health Organization; 2015.
30.
[Malawi]’ NSON, ICF. Malawi Demographic and Health Survey 2015–16. In: Office NS, ed. Zomba, Malawi, and Rockville, Maryland, USA.: NSO and ICF; 2017.
31.
Maliwichi-Nyirenda CP, Maliwichi LL. Medicinal plants used for contraception and pregnancy- related cases in Malawi: a case study of Mulanje District. J. Med. Plant Res. 2010;4(20):3024–30.
32.
Maliwichi-Nyirenda CP, Maliwichi LL. Medicinal plants used to induce labour and traditional techniques used in determination of onset of labour in pregnant women in Malawi: a case study of Mulanje District. J. Med. Plant Res. 2010;4(24):2609–14.
33.
Bullough CH. Analysis of maternal deaths in the central region of Malawi. East Afr Med J. 1981;58(1):25–36.PubMed
34.
Bullough CH, Leary WP. Herbal medicines used by traditional birth attendants in Malawi. Trop Geogr Med. 1982;34(1):81–5.PubMed
35.
Mataya R. Report on the Confidential Enquiry into Maternal Deaths in Malawi (2008–2012). In. Lilongwe 2015. World Health Organization.
36.
Lewycka S, Mwansambo C, Kazembe P, et al. A cluster randomised controlled trial of the community effectiveness of two interventions in rural Malawi to improve health care and to reduce maternal, newborn and infant mortality. Trials. 2010;11:88.
37.
Lewycka S, Mwansambo C, Rosato M, et al. Effect of women's groups and volunteer peer counselling on rates of mortality, morbidity, and health behaviours in mothers and children in rural Malawi (MaiMwana): a factorial, cluster-randomised controlled trial. Lancet (London, England). 2013;381(9879):1721–35.CrossRef
38.
Rosato M, Mwansambo C, Lewycka S, et al. MaiMwana women’s groups: a community mobilisation intervention to improve mother and child health and reduce mortality in rural Malawi. Malawi Med. J : the journal of Medical Association of Malawi. 2010;22(4):112–9.
39.
World Health Organisation. CLOSING THE GAP: policy into practice on social determinants of heath. Paper presented at: world conference on social determinants of health. Brazil: Rio De Janeiro; 2011.
40.
Stokoe U. Determinants of maternal mortality in the developing world. Aust N Z J Obstet Gynaecol. 1991;31(1):8–16.CrossRefPubMed
41.
Stanifer JW, Patel UD, Karia F, et al. The determinants of traditional medicine use in northern Tanzania: a mixed-methods study. PLoS One. 2015;10(4):e0122638.CrossRefPubMedPubMedCentral
42.
Laelago T, Yohannes T, Lemango F. Prevalence of herbal medicine use and associated factors among pregnant women attending antenatal care at public health facilities in Hossana town, southern Ethiopia: facility based cross sectional study. Archives of Public Health. 2016;74(1):7.CrossRefPubMedPubMedCentral
43.
Nyeko R, Tumwesigye NM, Halage AA. Prevalence and factors associated with use of herbal medicines during pregnancy among women attending postnatal clinics in Gulu district northern Uganda. BMC Pregnancy Childbirth. 2016;16(1):296.CrossRefPubMedPubMedCentral
44.
Baraldi AN, Enders CK. An introduction to modern missing data analyses. J Sch Psychol. 2010;48(1):5–37.CrossRefPubMed
45.
Cuzzolin L, Francini-Pesenti F, Verlato G, Joppi M, Baldelli P, Benoni G. Use of herbal products among 392 Italian pregnant women: focus on pregnancy outcome. Pharmacoepidemiol Drug Saf. 2010;19(11):1151–8.CrossRefPubMed
46.
Strandberg TE, Järvenpää AL, Vanhanen H, McKeigue PM. Birth outcome in relation to licorice consumption during pregnancy. Am J Epidemiol. 2001;153(11):1085–8.CrossRefPubMed
47.
Heitmann K, Nordeng H, Holst L. Pregnancy outcome after use of cranberry in pregnancy -- the Norwegian mother and child cohort study. BMC Complement. Altern. Med. 2013;13(1):345–65.CrossRefPubMedPubMedCentral
48.
Higgins P. Pharmacodynamics and pharmacokinetics. In: McKay GA, Walters MR, eds. Clinical pharmacology and therapeutics: lecture notes. 9th ed. Sussex: John Wiley & Sons, Ltd; 2013:3–10.
49.
Battista E. Pharmacology. 4th ed. London: Elsevier Ltd; 2002.
50.
51.
Chapman RR. Endangering safe motherhood in Mozambique: prenatal care as pregnancy risk. Soc Sci Med. 2003;57(2):355–74.CrossRefPubMed
52.
Malan DF, Neuba DFR. Traditional practices and medicinal plants use during pregnancy by Anyi-Ndenye women (eastern Côte d'Ivoire). Afr J Reprod Health. 2011;15(1):85–93.PubMed
53.
Panganai T, Shumba P. The African Pitocin - a midwife’s dilemma: the perception of women on the use of herbs in pregnancy and labour in Zimbabwe Gweru. Pan Afr. Med. J. 2016;25:9.CrossRefPubMedPubMedCentral
54.
Otoo P, Habib H, Ankomah A. Food prohibitions and other traditional practices in pregnancy: a qualitative study in western region of Ghana. Advances in Reproductive Sciences. 2015;3:41–9.CrossRef
55.
Dako-Gyeke P, Aikins M, Aryeetey R, Mccough L, Adongo PB. The influence of socio-cultural interpretations of pregnancy threats on health-seeking behavior among pregnant women in urban Accra Ghana. BMC Pregnancy and Childbirth. 2013;13(1):211.CrossRefPubMedPubMedCentral
56.
Bayisa B, Tatiparthi R, Mulisa E. Use of herbal medicine among pregnant women on antenatal Care at Nekemte Hospital, western Ethiopia. Jundishapur Journal of Natural Pharmaceutical Products. 2014;9(4):e17368.CrossRefPubMedPubMedCentral
57.
Mekuria AB, Erku DA, Gebresillassie BM, Birru EM, Tizazu B, Ahmedin A. Prevalence and associated factors of herbal medicine use among pregnant women on antenatal care follow-up at University of Gondar referral and teaching hospital, Ethiopia: a cross-sectional study. BMC Complement Altern Med. 2017;17(1):86.CrossRefPubMedPubMedCentral
Metadata
Title
Associations between the use of herbal medicines and adverse pregnancy outcomes in rural Malawi: a secondary analysis of randomised controlled trial data
Authors
Collins Zamawe
Carina King
Hannah Maria Jennings
Edward Fottrell
Publication date
01-12-2018
Publisher
BioMed Central
Published in
BMC Complementary Medicine and Therapies / Issue 1/2018
Electronic ISSN: 2662-7671
DOI
https://doi.org/10.1186/s12906-018-2203-z

Other articles of this Issue 1/2018

BMC Complementary Medicine and Therapies 1/2018 Go to the issue

Research article

Hand-foot-mouth disease and use of steroids, intravenous immunoglobulin, and traditional Chinese herbs in a tertiary hospital in Shantou, China

Research article

Protective effects and mechanisms of Terminalia catappa L. methenolic extract on hydrogen-peroxide-induced oxidative stress in human skin fibroblasts

Research article

Screening of Baccaurea ramiflora (Lour.) extracts for cytotoxic, analgesic, anti-inflammatory, neuropharmacological and antidiarrheal activities

Study protocol

The effects of green cardamom supplementation on blood glucose, lipids profile, oxidative stress, sirtuin-1 and irisin in type 2 diabetic patients: a study protocol for a randomized placebo-controlled clinical trial

Research article

Comparative efficacy of Chinese herbal injections for treating acute cerebral infarction: a network meta-analysis of randomized controlled trials

Research article

Huatuo Zaizao pill ameliorates cognitive impairment of APP/PS1 transgenic mice by improving synaptic plasticity and reducing Aβ deposition